Trademark: CTI 2256642
Word
CTI
Device Descrption:
6 DOTS,1 IS DOT OF LTR I
ID
2256642
Trademark Type
Figurative
Status
Protected: Registered/protected
Application Date
26 January 2022
Registration Date
26 January 2022
Renewal Date
26 January 2032
Owner(s)
Service
Herbert Smith Freehills
Goods and Services:
Class 5:
Pharmaceutical preparations used for the treatment of cancer; and pharmaceutical preparations used for the treatment of immunological and inflammatory diseases, infections secondary to the oncologic disease, and the management of pain accompanying either the disease process or the associated treatment regimens.
Pharmaceutical preparations used for the treatment of cancer; and pharmaceutical preparations used for the treatment of immunological and inflammatory diseases, infections secondary to the oncologic disease, and the management of pain accompanying either the disease process or the associated treatment regimens.
Class 16:
Brochures, newsletters, and pamphlets relating to medical issues, procedures, disease symptoms, patient support and community building.
Brochures, newsletters, and pamphlets relating to medical issues, procedures, disease symptoms, patient support and community building.
Class 42:
Research and development of pharmaceutical preparations; product research and development for others in the field of pharmaceutical preparations; product research and development services, namely, assessing intended target recipients of pharmaceutical preparations and positioning pharmaceutical preparations for success in clinical development and commercial use; and providing technical consultation in the field of pharmaceutical product research and development.
Research and development of pharmaceutical preparations; product research and development for others in the field of pharmaceutical preparations; product research and development services, namely, assessing intended target recipients of pharmaceutical preparations and positioning pharmaceutical preparations for success in clinical development and commercial use; and providing technical consultation in the field of pharmaceutical product research and development.